What is Paul Hartmann AG Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Paul Hartmann AG's annualized net income for the quarter that ended in Dec. 2023 was €33 Mil. Paul Hartmann AG's average shareholder tangible equity for the quarter that ended in Dec. 2023 was €809 Mil. Therefore, Paul Hartmann AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 4.14%.
The historical rank and industry rank for Paul Hartmann AG's Return-on-Tangible-Equity or its related term are showing as below:
FRA:PHH2'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.45 Med: 12.78 Max: 15.09
Current: 3.47
During the past 13 years, Paul Hartmann AG's highest Return-on-Tangible-Equity was 15.09%. The lowest was 3.45%. And the median was 12.78%.
FRA:PHH2's Return-on-Tangible-Equity is ranked better than 53.35% of 761
companies
in the Medical Devices & Instruments industry
Industry Median: 1.87
vs FRA:PHH2: 3.47
Paul Hartmann AG Return-on-Tangible-Equity Historical Data
The historical data trend for Paul Hartmann AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Paul Hartmann AG's Return-on-Tangible-Equity
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's Return-on-Tangible-Equity falls into.
Paul Hartmann AG Return-on-Tangible-Equity Calculation
Paul Hartmann AG's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2023) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Paul Hartmann AG (FRA:PHH2) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Paul Hartmann AG Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Paul Hartmann AG's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PHH2 has been successfully added to your 